PubRank

J K Rose

Author PubWeight™ 310.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992 17.81
2 Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 1995 9.08
3 Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions. J Virol 1981 7.97
4 5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A 1976 6.78
5 Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell 1981 5.38
6 Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell 1980 5.32
7 Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell 1983 5.02
8 An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 2001 4.79
9 Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells. Cell 1982 4.74
10 Folding and assembly of viral membrane proteins. Virology 1993 4.63
11 Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A 1978 4.59
12 Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins. J Virol 1981 4.49
13 Tryptophan messenger ribonucleic acid elongation rates and steady-state levels of tryptophan operon enzymes under various growth conditions. J Mol Biol 1970 3.89
14 The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol 1996 3.89
15 Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol 1989 3.81
16 Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science 1989 3.59
17 Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science 1985 3.54
18 Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A 1996 3.54
19 Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 1997 3.46
20 Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem 1975 3.44
21 The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell 1989 3.24
22 Translation of individual species of vesicular stomatitis viral mRNA. J Virol 1975 3.12
23 Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein. J Cell Biol 1988 3.10
24 Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol 1998 3.07
25 Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol 1999 3.04
26 5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature 1977 3.00
27 A specific transmembrane domain of a coronavirus E1 glycoprotein is required for its retention in the Golgi region. J Cell Biol 1987 2.97
28 CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol 1990 2.96
29 The presence of cysteine in the cytoplasmic domain of the vesicular stomatitis virus glycoprotein is required for palmitate addition. Proc Natl Acad Sci U S A 1984 2.91
30 Vesicular stomatitis virus glycoprotein is anchored in the viral membrane by a hydrophobic domain near the COOH terminus. Proc Natl Acad Sci U S A 1980 2.87
31 Nucleotide sequence complexities, molecular weights, and poly(A) content of the vesicular stomatitis virus mRNA species. J Virol 1975 2.85
32 Translation in vitro of vesicular stomatitis virus mRNA lacking 5'-terminal 7-methylguanosine. Nature 1976 2.81
33 A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol 1985 2.78
34 Structural requirements of a membrane-spanning domain for protein anchoring and cell surface transport. Cell 1985 2.76
35 Signals determining protein tyrosine kinase and glycosyl-phosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Mol Cell Biol 1994 2.70
36 A single amino acid substitution in a hydrophobic domain causes temperature-sensitive cell-surface transport of a mutant viral glycoprotein. J Virol 1985 2.68
37 Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J 1998 2.64
38 Fc receptor isoforms exhibit distinct abilities for coated pit localization as a result of cytoplasmic domain heterogeneity. Cell 1989 2.58
39 Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein. J Biol Chem 1990 2.56
40 Membrane association of functional vesicular stomatitis virus matrix protein in vivo. J Virol 1993 2.56
41 Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J Virol 1993 2.54
42 Conversion of a secretory protein into a transmembrane protein results in its transport to the Golgi complex but not to the cell surface. Cell 1984 2.49
43 Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 1990 2.48
44 Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A 1980 2.46
45 Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 1993 2.38
46 Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding. J Biol Chem 1988 2.30
47 Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc Natl Acad Sci U S A 1998 2.29
48 Lateral diffusion of membrane-spanning and glycosylphosphatidylinositol-linked proteins: toward establishing rules governing the lateral mobility of membrane proteins. J Cell Biol 1991 2.28
49 Regulation of in vitro transcription of the tryptophan operon by purified RNA polymerase in the presence of partially purified repressor and tryptophan. Nat New Biol 1973 2.20
50 Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains. J Cell Biol 1996 2.19
51 Nucleotide sequence of a cDNA clone encoding the entire glycoprotein from the New Jersey serotype of vesicular stomatitis virus. J Virol 1983 2.19
52 Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. J Virol 2000 2.17
53 Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J Cell Biol 1983 2.14
54 Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 1994 2.08
55 High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol 1997 2.07
56 A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH. Science 1984 2.07
57 Glycosylation allows cell-surface transport of an anchored secretory protein. Cell 1985 2.06
58 Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase. Mol Cell Biol 1990 2.06
59 Nucleotide sequences of ribosome recgonition sites in messenger RNAs of vesicular stomatitis virus. Proc Natl Acad Sci U S A 1977 2.05
60 Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 1999 2.03
61 Interaction of the operator of the tryptophan operon with repressor. Proc Natl Acad Sci U S A 1974 2.02
62 N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J Virol 1986 2.01
63 Complete sequences of the ribosome recognition sites in vesicular stomatitis virus mRNAs: recognition by the 40S and 80S complexes. Cell 1978 1.97
64 Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. J Virol 1994 1.93
65 Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg 1997 1.91
66 Metabolic regulation of the tryptophan operon of Escherichia coli: repressor-independent regulation of transcription initiation frequency. J Mol Biol 1972 1.89
67 Cytoplasmic domains of cellular and viral integral membrane proteins substitute for the cytoplasmic domain of the vesicular stomatitis virus glycoprotein in transport to the plasma membrane. J Cell Biol 1986 1.88
68 Relative importance of 7-methylguanosine in ribosome binding and translation of vesicular stomatitis virus mRNA in wheat germ and reticulocyte cell-free systems. J Biol Chem 1977 1.85
69 Evidence for the loop model of signal-sequence insertion into the endoplasmic reticulum. Proc Natl Acad Sci U S A 1988 1.84
70 Giant heterogeneous polyadenylic acid on vesicular stomatitis virus mRNA synthesized in vitro in the presence of S-adenosylhomocysteine. J Virol 1977 1.80
71 The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex. Proc Natl Acad Sci U S A 1990 1.79
72 Incorporation of a charged amino acid into the membrane-spanning domain blocks cell surface transport but not membrane anchoring of a viral glycoprotein. Mol Cell Biol 1985 1.79
73 Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology 1991 1.77
74 Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field. Virology 1998 1.75
75 Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies. J Virol 2000 1.74
76 Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J Virol 1997 1.72
77 5'-terminus of Moloney murine leukemia virus 35s RNA is m7G5' ppp5' GmpCp. J Virol 1976 1.70
78 Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids. J Virol 1994 1.68
79 Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 2001 1.68
80 Nucleotide sequences from the 3'-ends of vesicular stomatitis virus mRNA's as determined from cloned DNA. J Virol 1979 1.64
81 Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein. J Virol 1989 1.64
82 Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge. J Virol 2001 1.58
83 Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology 1996 1.58
84 Influence of new glycosylation sites on expression of the vesicular stomatitis virus G protein at the plasma membrane. J Biol Chem 1988 1.55
85 Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins. J Virol 1995 1.55
86 Homology between the glycoproteins of vesicular stomatitis virus and rabies virus. J Virol 1982 1.55
87 Conditional expression of the vesicular stomatitis virus glycoprotein gene in Escherichia coli. Proc Natl Acad Sci U S A 1981 1.53
88 Effects of mutations in three domains of the vesicular stomatitis viral glycoprotein on its lateral diffusion in the plasma membrane. J Cell Biol 1987 1.53
89 Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization. J Cell Biol 1992 1.47
90 Tryptophanyl-tRNA and tryptophanyl-tRNA synthetase are not required for in vitro repression of the tryptophan operon. Nat New Biol 1973 1.46
91 Auxin-regulated genes encoding cell wall-modifying proteins are expressed during early tomato fruit growth. Plant Physiol 2000 1.45
92 Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J Virol 1999 1.43
93 Limited correlation between expansin gene expression and elongation growth rate. Plant Physiol 2000 1.42
94 Normal replication of vesicular stomatitis virus without C proteins. Virology 1996 1.41
95 Coronavirus E1 glycoprotein expressed from cloned cDNA localizes in the Golgi region. J Virol 1987 1.41
96 A fusion-defective mutant of the vesicular stomatitis virus glycoprotein. J Virol 1990 1.37
97 Cell-surface expression of a membrane-anchored form of the human chorionic gonadotropin alpha subunit. J Biol Chem 1988 1.36
98 Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J Biol Chem 1992 1.35
99 Auxin regulation and spatial localization of an endo-1,4-beta-D-glucanase and a xyloglucan endotransglycosylase in expanding tomato hypocotyls. Plant J 1997 1.34
100 Replacement of the cytoplasmic domain alters sorting of a viral glycoprotein in polarized cells. Proc Natl Acad Sci U S A 1987 1.33
101 Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology 2000 1.32
102 Polygalacturonase gene expression in ripe melon fruit supports a role for polygalacturonase in ripening-associated pectin disassembly. Plant Physiol 1998 1.30
103 Sequential synthesis of 5'-proximal vesicular stomatitis virus mRNA sequences. J Virol 1982 1.24
104 A membrane-anchored form but not the secretory form of human chorionic gonadotropin-alpha chain acquires polylactosaminoglycan. J Biol Chem 1988 1.23
105 RNA synthesis of vesicular stomatitis virus. VII. Complete separation of the mRNA's of vesicular stomatitis virus by duplex formation. J Virol 1977 1.20
106 Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum. J Virol 1992 1.20
107 Brefeldin A sensitivity and resistance in Schizosaccharomyces pombe. Isolation of multiple genes conferring resistance. J Biol Chem 1994 1.19
108 Identification of palmitoylation sites on CD4, the human immunodeficiency virus receptor. J Biol Chem 1992 1.13
109 Carboxy-terminal SEKDEL sequences retard but do not retain two secretory proteins in the endoplasmic reticulum. J Cell Biol 1989 1.12
110 Transcription of the operator proximal and distal ends of the tryptophan operon: evidence that trpE and trpA are the delimiting structural genes. J Bacteriol 1971 1.10
111 A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions. Virology 1998 1.09
112 Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 1994 1.06
113 Dynamic equilibrium between vesicular stomatitis virus glycoprotein monomers and trimers in the Golgi and at the cell surface. J Virol 1993 1.03
114 Characterization of a tomato xyloglucan endotransglycosylase gene that is down-regulated by auxin in etiolated hypocotyls. Plant Physiol 2001 1.03
115 Dissociation and reassociation of oligomeric viral glycoprotein subunits in the endoplasmic reticulum. J Virol 1991 1.00
116 Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions. Virology 1991 0.99
117 Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc Natl Acad Sci U S A 1993 0.98
118 A critical role for the polarization of membrane recycling in cell motility. Cell Motil Cytoskeleton 1987 0.97
119 Redesign and genetic dissection of the rhabdoviruses. Adv Virus Res 1999 0.96
120 Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses. Virology 2001 0.94
121 A single-amino-acid substitution eliminates the stringent carbohydrate requirement for intracellular transport of a viral glycoprotein. J Virol 1989 0.93
122 Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus. Proc Natl Acad Sci U S A 1985 0.91
123 Enteral feeding intolerance: an indicator of sepsis-associated mortality in burned children. Arch Surg 1997 0.90
124 Expression of additional genes in a vector derived from a minimal RNA virus. Virology 1996 0.90
125 Effects of altered cytoplasmic domains on transport of the vesicular stomatitis virus glycoprotein are transferable to other proteins. Mol Cell Biol 1988 0.90
126 The lateral mobility of some membrane proteins is determined by their ectodomains. Biophys J 1992 0.90
127 Optimization of cottontail rabbit papilloma virus challenge technique. J Virol Methods 2001 0.89
128 Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice. Virus Res 2000 0.88
129 Characterization of a novel Schizosaccharomyces pombe multidrug resistance transporter conferring brefeldin A resistance. Biochem Biophys Res Commun 1995 0.87
130 Amino-terminal mutation of the vesicular stomatitis virus glycoprotein does not affect its fusion activity. J Virol 1986 0.85
131 An internalized amino-terminal signal sequence retains full activity in vivo but not in vitro. J Biol Chem 1987 0.85
132 Characterization of a nuclear protein conferring brefeldin A resistance in Schizosaccharomyces pombe. J Biol Chem 1996 0.84
133 Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids 1991 0.84
134 Cadaver skin allograft and the transmission of human cytomegalovirus in burn patients: benefits clearly outweigh risks. J Am Coll Surg 1996 0.81
135 Liposome-mediated transfection. Curr Protoc Immunol 2001 0.78
136 Replication of primary HIV-1 isolates is inhibited in PM1 cells expressing sCD4-KDEL. Virology 1996 0.78
137 The production of anti-A1 agglutinins in A-like rabbits injected with human group a1 secretor saliva. Immunol Commun 1980 0.75
138 Incidence, histological pattern, and clinical outcome of rejection episodes occurring in the late posttransplant period. Transplantation 1985 0.75
139 The production of anti-a1 agglutinins in A-like rabbits injected with human group A1 erythrocytes. Immunol Commun 1980 0.75